Protocol# SERES-101: A Multiple Dose Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects with Mild-to-Moderate Ulcerative Colitis

Project: Research project

Project Details

StatusFinished
Effective start/end date8/17/16 → 8/17/19

Funding

  • Parexel (Protocol# SERES-101)
  • Seres Therapeutics, Inc. (Protocol# SERES-101)